Bunkerhill Health vs Iterative Health

SKOUT from Iterative Health is computer-aided polyp detection on the live colonoscopy video feed, with six openFDA decisions under product code QNP between August 2022 and December 2025. A sponsor-run randomized trial in Gastroenterology, 22 endoscopists at five centers, compared 677 standard colonoscopies with 682 using the device: adenomas per colonoscopy were 0.83 standard versus 1.05 with SKOUT (P=.002), and adenoma detection rate was 43.9% versus 47.8% (P=.065, not significant). The company's home page now leads with clinical research and a $77 million Series C. A GI practice or endoscopy center is the buyer.

Bunkerhill's homepage describes agents for oral-oncolytic prior authorization through appeal and heart failure follow-up, with its clearances in CT calcium, bone density, aortic and ECG algorithms. A health system buying agent work across referrals and follow-up is the buyer there.

Polyp detection during colonoscopy and agent work on authorizations and follow-up are different purchases. A GI practice inside a health system could sit on both lists.